Published 1997
| Version v1.0.0
Journal Article
Open
Sumatriptan Nasal Spray for Acute Migraine
Creators
Abstract
The efficacy and side effects of intranasal sumatriptan (20 mg, 10 mg) or placebo in the treatment of a single migraine attack were evaluated in two randomized, double-blind, multicenter studies of 409 and 436 adult patients, funded by Glaxo Wellcome.Files
PNB-11-95.pdf
Files
(1.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:e22f76f4576f7fbd4d96b887005c35ae
|
1.2 MB | Preview Download |
Additional details
Identifiers
- Other
- PNB-11-95
Dates
- Created
-
1997When the item was originally created.